nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Ill-defined disorder—Cisplatin—bone cancer	0.00337	0.00338	CcSEcCtD
Carbidopa—Anaemia—Cisplatin—bone cancer	0.00336	0.00336	CcSEcCtD
Carbidopa—Phlebitis—Doxorubicin—bone cancer	0.00333	0.00333	CcSEcCtD
Carbidopa—Hot flush—Epirubicin—bone cancer	0.00331	0.00332	CcSEcCtD
Carbidopa—Menopausal symptoms—Epirubicin—bone cancer	0.00329	0.00329	CcSEcCtD
Carbidopa—Malaise—Cisplatin—bone cancer	0.00328	0.00328	CcSEcCtD
Carbidopa—Leukopenia—Cisplatin—bone cancer	0.00325	0.00326	CcSEcCtD
Carbidopa—Dermatitis bullous—Epirubicin—bone cancer	0.00324	0.00325	CcSEcCtD
Carbidopa—Purpura—Epirubicin—bone cancer	0.00322	0.00322	CcSEcCtD
Carbidopa—Vascular purpura—Doxorubicin—bone cancer	0.00321	0.00321	CcSEcCtD
Carbidopa—Convulsion—Cisplatin—bone cancer	0.00315	0.00315	CcSEcCtD
Carbidopa—Ataxia—Methotrexate—bone cancer	0.00312	0.00312	CcSEcCtD
Carbidopa—Hyponatraemia—Epirubicin—bone cancer	0.00311	0.00312	CcSEcCtD
Carbidopa—Diplopia—Epirubicin—bone cancer	0.0031	0.0031	CcSEcCtD
Carbidopa—Pain in extremity—Epirubicin—bone cancer	0.0031	0.0031	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.0031	0.0031	CcSEcCtD
Carbidopa—Anxiety—Cisplatin—bone cancer	0.00308	0.00309	CcSEcCtD
Carbidopa—Hot flush—Doxorubicin—bone cancer	0.00307	0.00307	CcSEcCtD
Carbidopa—Discomfort—Cisplatin—bone cancer	0.00306	0.00306	CcSEcCtD
Carbidopa—Menopausal symptoms—Doxorubicin—bone cancer	0.00304	0.00304	CcSEcCtD
Carbidopa—Dermatitis bullous—Doxorubicin—bone cancer	0.003	0.00301	CcSEcCtD
Carbidopa—Purpura—Doxorubicin—bone cancer	0.00298	0.00298	CcSEcCtD
Carbidopa—Oedema—Cisplatin—bone cancer	0.00297	0.00297	CcSEcCtD
Carbidopa—Infection—Cisplatin—bone cancer	0.00295	0.00295	CcSEcCtD
Carbidopa—Ataxia—Epirubicin—bone cancer	0.00292	0.00292	CcSEcCtD
Carbidopa—Thrombocytopenia—Cisplatin—bone cancer	0.00291	0.00291	CcSEcCtD
Carbidopa—Blood creatinine increased—Epirubicin—bone cancer	0.0029	0.00291	CcSEcCtD
Carbidopa—Hyponatraemia—Doxorubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.00287	0.00287	CcSEcCtD
Carbidopa—Pain in extremity—Doxorubicin—bone cancer	0.00287	0.00287	CcSEcCtD
Carbidopa—Diplopia—Doxorubicin—bone cancer	0.00287	0.00287	CcSEcCtD
Carbidopa—Hyperhidrosis—Cisplatin—bone cancer	0.00287	0.00287	CcSEcCtD
Carbidopa—Orthostatic hypotension—Epirubicin—bone cancer	0.00283	0.00283	CcSEcCtD
Carbidopa—Anorexia—Cisplatin—bone cancer	0.00283	0.00283	CcSEcCtD
Carbidopa—Hypotension—Cisplatin—bone cancer	0.00277	0.00278	CcSEcCtD
Carbidopa—Nasopharyngitis—Epirubicin—bone cancer	0.00277	0.00278	CcSEcCtD
Carbidopa—Gastritis—Epirubicin—bone cancer	0.00274	0.00275	CcSEcCtD
Carbidopa—Ataxia—Doxorubicin—bone cancer	0.0027	0.0027	CcSEcCtD
Carbidopa—Blood creatinine increased—Doxorubicin—bone cancer	0.00269	0.00269	CcSEcCtD
Carbidopa—Dysphagia—Epirubicin—bone cancer	0.00268	0.00268	CcSEcCtD
Carbidopa—Paraesthesia—Cisplatin—bone cancer	0.00266	0.00267	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Methotrexate—bone cancer	0.00266	0.00266	CcSEcCtD
Carbidopa—Dyspnoea—Cisplatin—bone cancer	0.00265	0.00265	CcSEcCtD
Carbidopa—Orthostatic hypotension—Doxorubicin—bone cancer	0.00262	0.00262	CcSEcCtD
Carbidopa—Decreased appetite—Cisplatin—bone cancer	0.00258	0.00258	CcSEcCtD
Carbidopa—Nasopharyngitis—Doxorubicin—bone cancer	0.00257	0.00257	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Cisplatin—bone cancer	0.00256	0.00256	CcSEcCtD
Carbidopa—Depression—Methotrexate—bone cancer	0.00255	0.00255	CcSEcCtD
Carbidopa—Gastritis—Doxorubicin—bone cancer	0.00254	0.00254	CcSEcCtD
Carbidopa—Pain—Cisplatin—bone cancer	0.00254	0.00254	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Epirubicin—bone cancer	0.00249	0.00249	CcSEcCtD
Carbidopa—Dysphagia—Doxorubicin—bone cancer	0.00248	0.00248	CcSEcCtD
Carbidopa—Pollakiuria—Epirubicin—bone cancer	0.00248	0.00248	CcSEcCtD
Carbidopa—Feeling abnormal—Cisplatin—bone cancer	0.00245	0.00245	CcSEcCtD
Carbidopa—Weight increased—Epirubicin—bone cancer	0.00244	0.00244	CcSEcCtD
Carbidopa—Weight decreased—Epirubicin—bone cancer	0.00242	0.00243	CcSEcCtD
Carbidopa—Agranulocytosis—Methotrexate—bone cancer	0.00238	0.00239	CcSEcCtD
Carbidopa—Body temperature increased—Cisplatin—bone cancer	0.00235	0.00235	CcSEcCtD
Carbidopa—Neuropathy peripheral—Epirubicin—bone cancer	0.00234	0.00234	CcSEcCtD
Carbidopa—Urinary tract infection—Epirubicin—bone cancer	0.00232	0.00233	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Doxorubicin—bone cancer	0.0023	0.00231	CcSEcCtD
Carbidopa—Haemoglobin—Methotrexate—bone cancer	0.0023	0.00231	CcSEcCtD
Carbidopa—Haemorrhage—Methotrexate—bone cancer	0.00229	0.00229	CcSEcCtD
Carbidopa—Pollakiuria—Doxorubicin—bone cancer	0.00229	0.00229	CcSEcCtD
Carbidopa—Urinary tract disorder—Methotrexate—bone cancer	0.00226	0.00227	CcSEcCtD
Carbidopa—Weight increased—Doxorubicin—bone cancer	0.00226	0.00226	CcSEcCtD
Carbidopa—Urethral disorder—Methotrexate—bone cancer	0.00225	0.00225	CcSEcCtD
Carbidopa—Weight decreased—Doxorubicin—bone cancer	0.00224	0.00225	CcSEcCtD
Carbidopa—Agranulocytosis—Epirubicin—bone cancer	0.00223	0.00223	CcSEcCtD
Carbidopa—Hypersensitivity—Cisplatin—bone cancer	0.00219	0.00219	CcSEcCtD
Carbidopa—Neuropathy peripheral—Doxorubicin—bone cancer	0.00217	0.00217	CcSEcCtD
Carbidopa—Haemoglobin—Epirubicin—bone cancer	0.00216	0.00216	CcSEcCtD
Carbidopa—Rhinitis—Epirubicin—bone cancer	0.00215	0.00215	CcSEcCtD
Carbidopa—Urinary tract infection—Doxorubicin—bone cancer	0.00215	0.00215	CcSEcCtD
Carbidopa—Haemorrhage—Epirubicin—bone cancer	0.00214	0.00215	CcSEcCtD
Carbidopa—Hypoaesthesia—Epirubicin—bone cancer	0.00213	0.00214	CcSEcCtD
Carbidopa—Asthenia—Cisplatin—bone cancer	0.00213	0.00213	CcSEcCtD
Carbidopa—Urinary tract disorder—Epirubicin—bone cancer	0.00212	0.00212	CcSEcCtD
Carbidopa—Urethral disorder—Epirubicin—bone cancer	0.0021	0.0021	CcSEcCtD
Carbidopa—Agranulocytosis—Doxorubicin—bone cancer	0.00206	0.00207	CcSEcCtD
Carbidopa—Diarrhoea—Cisplatin—bone cancer	0.00203	0.00203	CcSEcCtD
Carbidopa—Alopecia—Methotrexate—bone cancer	0.00203	0.00203	CcSEcCtD
Carbidopa—Mental disorder—Methotrexate—bone cancer	0.00201	0.00201	CcSEcCtD
Carbidopa—Haemoglobin—Doxorubicin—bone cancer	0.00199	0.002	CcSEcCtD
Carbidopa—Flushing—Epirubicin—bone cancer	0.00199	0.00199	CcSEcCtD
Carbidopa—Rhinitis—Doxorubicin—bone cancer	0.00199	0.00199	CcSEcCtD
Carbidopa—Haemorrhage—Doxorubicin—bone cancer	0.00198	0.00199	CcSEcCtD
Carbidopa—Hypoaesthesia—Doxorubicin—bone cancer	0.00197	0.00198	CcSEcCtD
Carbidopa—Urinary tract disorder—Doxorubicin—bone cancer	0.00196	0.00196	CcSEcCtD
Carbidopa—Dysgeusia—Methotrexate—bone cancer	0.00195	0.00196	CcSEcCtD
Carbidopa—Urethral disorder—Doxorubicin—bone cancer	0.00195	0.00195	CcSEcCtD
Carbidopa—Back pain—Methotrexate—bone cancer	0.00193	0.00193	CcSEcCtD
Carbidopa—Alopecia—Epirubicin—bone cancer	0.0019	0.0019	CcSEcCtD
Carbidopa—Vomiting—Cisplatin—bone cancer	0.00189	0.00189	CcSEcCtD
Carbidopa—Vision blurred—Methotrexate—bone cancer	0.00188	0.00188	CcSEcCtD
Carbidopa—Mental disorder—Epirubicin—bone cancer	0.00188	0.00188	CcSEcCtD
Carbidopa—Rash—Cisplatin—bone cancer	0.00187	0.00187	CcSEcCtD
Carbidopa—Dermatitis—Cisplatin—bone cancer	0.00187	0.00187	CcSEcCtD
Carbidopa—Ill-defined disorder—Methotrexate—bone cancer	0.00185	0.00185	CcSEcCtD
Carbidopa—Anaemia—Methotrexate—bone cancer	0.00184	0.00185	CcSEcCtD
Carbidopa—Flushing—Doxorubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Carbidopa—Flatulence—Epirubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Carbidopa—Tension—Epirubicin—bone cancer	0.00183	0.00183	CcSEcCtD
Carbidopa—Dysgeusia—Epirubicin—bone cancer	0.00183	0.00183	CcSEcCtD
Carbidopa—Nervousness—Epirubicin—bone cancer	0.00181	0.00182	CcSEcCtD
Carbidopa—Back pain—Epirubicin—bone cancer	0.00181	0.00181	CcSEcCtD
Carbidopa—Malaise—Methotrexate—bone cancer	0.0018	0.0018	CcSEcCtD
Carbidopa—Muscle spasms—Epirubicin—bone cancer	0.0018	0.0018	CcSEcCtD
Carbidopa—Leukopenia—Methotrexate—bone cancer	0.00179	0.00179	CcSEcCtD
Carbidopa—Nausea—Cisplatin—bone cancer	0.00176	0.00176	CcSEcCtD
Carbidopa—Vision blurred—Epirubicin—bone cancer	0.00176	0.00176	CcSEcCtD
Carbidopa—Alopecia—Doxorubicin—bone cancer	0.00175	0.00176	CcSEcCtD
Carbidopa—Cough—Methotrexate—bone cancer	0.00174	0.00174	CcSEcCtD
Carbidopa—Mental disorder—Doxorubicin—bone cancer	0.00174	0.00174	CcSEcCtD
Carbidopa—Ill-defined disorder—Epirubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Carbidopa—Convulsion—Methotrexate—bone cancer	0.00173	0.00173	CcSEcCtD
Carbidopa—Anaemia—Epirubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Carbidopa—Agitation—Epirubicin—bone cancer	0.00172	0.00172	CcSEcCtD
Carbidopa—Flatulence—Doxorubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Carbidopa—Chest pain—Methotrexate—bone cancer	0.0017	0.0017	CcSEcCtD
Carbidopa—Tension—Doxorubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Carbidopa—Dysgeusia—Doxorubicin—bone cancer	0.00169	0.00169	CcSEcCtD
Carbidopa—Malaise—Epirubicin—bone cancer	0.00168	0.00169	CcSEcCtD
Carbidopa—Discomfort—Methotrexate—bone cancer	0.00168	0.00168	CcSEcCtD
Carbidopa—Nervousness—Doxorubicin—bone cancer	0.00168	0.00168	CcSEcCtD
Carbidopa—Syncope—Epirubicin—bone cancer	0.00167	0.00168	CcSEcCtD
Carbidopa—Leukopenia—Epirubicin—bone cancer	0.00167	0.00167	CcSEcCtD
Carbidopa—Back pain—Doxorubicin—bone cancer	0.00167	0.00167	CcSEcCtD
Carbidopa—Muscle spasms—Doxorubicin—bone cancer	0.00166	0.00166	CcSEcCtD
Carbidopa—Palpitations—Epirubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Carbidopa—Confusional state—Methotrexate—bone cancer	0.00164	0.00164	CcSEcCtD
Carbidopa—Loss of consciousness—Epirubicin—bone cancer	0.00164	0.00164	CcSEcCtD
Carbidopa—Cough—Epirubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Carbidopa—Vision blurred—Doxorubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Carbidopa—Convulsion—Epirubicin—bone cancer	0.00162	0.00162	CcSEcCtD
Carbidopa—Infection—Methotrexate—bone cancer	0.00162	0.00162	CcSEcCtD
Carbidopa—Hypertension—Epirubicin—bone cancer	0.00161	0.00161	CcSEcCtD
Carbidopa—Ill-defined disorder—Doxorubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Carbidopa—Anaemia—Doxorubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Carbidopa—Thrombocytopenia—Methotrexate—bone cancer	0.00159	0.0016	CcSEcCtD
Carbidopa—Chest pain—Epirubicin—bone cancer	0.00159	0.00159	CcSEcCtD
Carbidopa—Agitation—Doxorubicin—bone cancer	0.00159	0.00159	CcSEcCtD
Carbidopa—Anxiety—Epirubicin—bone cancer	0.00158	0.00159	CcSEcCtD
Carbidopa—Hyperhidrosis—Methotrexate—bone cancer	0.00157	0.00158	CcSEcCtD
Carbidopa—Discomfort—Epirubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Carbidopa—Malaise—Doxorubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Carbidopa—Dry mouth—Epirubicin—bone cancer	0.00155	0.00156	CcSEcCtD
Carbidopa—Anorexia—Methotrexate—bone cancer	0.00155	0.00155	CcSEcCtD
Carbidopa—Syncope—Doxorubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Carbidopa—Leukopenia—Doxorubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Carbidopa—Confusional state—Epirubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Carbidopa—Palpitations—Doxorubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Carbidopa—Oedema—Epirubicin—bone cancer	0.00152	0.00153	CcSEcCtD
Carbidopa—Hypotension—Methotrexate—bone cancer	0.00152	0.00152	CcSEcCtD
Carbidopa—Loss of consciousness—Doxorubicin—bone cancer	0.00152	0.00152	CcSEcCtD
Carbidopa—Infection—Epirubicin—bone cancer	0.00151	0.00152	CcSEcCtD
Carbidopa—Cough—Doxorubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Carbidopa—Shock—Epirubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Carbidopa—Convulsion—Doxorubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Carbidopa—Thrombocytopenia—Epirubicin—bone cancer	0.00149	0.00149	CcSEcCtD
Carbidopa—Hypertension—Doxorubicin—bone cancer	0.00149	0.00149	CcSEcCtD
Carbidopa—Hyperhidrosis—Epirubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Carbidopa—Insomnia—Methotrexate—bone cancer	0.00147	0.00147	CcSEcCtD
Carbidopa—Chest pain—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Carbidopa—Anxiety—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Carbidopa—Paraesthesia—Methotrexate—bone cancer	0.00146	0.00146	CcSEcCtD
Carbidopa—Discomfort—Doxorubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Carbidopa—Anorexia—Epirubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Carbidopa—Dyspnoea—Methotrexate—bone cancer	0.00145	0.00145	CcSEcCtD
Carbidopa—Somnolence—Methotrexate—bone cancer	0.00145	0.00145	CcSEcCtD
Carbidopa—Dry mouth—Doxorubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Carbidopa—Dyspepsia—Methotrexate—bone cancer	0.00143	0.00143	CcSEcCtD
Carbidopa—Hypotension—Epirubicin—bone cancer	0.00142	0.00143	CcSEcCtD
Carbidopa—Confusional state—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Carbidopa—Decreased appetite—Methotrexate—bone cancer	0.00142	0.00142	CcSEcCtD
Carbidopa—Oedema—Doxorubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Methotrexate—bone cancer	0.00141	0.00141	CcSEcCtD
Carbidopa—Fatigue—Methotrexate—bone cancer	0.0014	0.00141	CcSEcCtD
Carbidopa—Infection—Doxorubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Carbidopa—Pain—Methotrexate—bone cancer	0.00139	0.00139	CcSEcCtD
Carbidopa—Shock—Doxorubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Carbidopa—Thrombocytopenia—Doxorubicin—bone cancer	0.00138	0.00138	CcSEcCtD
Carbidopa—Insomnia—Epirubicin—bone cancer	0.00138	0.00138	CcSEcCtD
Carbidopa—Paraesthesia—Epirubicin—bone cancer	0.00137	0.00137	CcSEcCtD
Carbidopa—Hyperhidrosis—Doxorubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Carbidopa—Dyspnoea—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Carbidopa—Somnolence—Epirubicin—bone cancer	0.00135	0.00136	CcSEcCtD
Carbidopa—Anorexia—Doxorubicin—bone cancer	0.00134	0.00135	CcSEcCtD
Carbidopa—Feeling abnormal—Methotrexate—bone cancer	0.00134	0.00134	CcSEcCtD
Carbidopa—Dyspepsia—Epirubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Carbidopa—Gastrointestinal pain—Methotrexate—bone cancer	0.00133	0.00133	CcSEcCtD
Carbidopa—Decreased appetite—Epirubicin—bone cancer	0.00132	0.00133	CcSEcCtD
Carbidopa—Hypotension—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Epirubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Carbidopa—Fatigue—Epirubicin—bone cancer	0.00131	0.00132	CcSEcCtD
Carbidopa—Pain—Epirubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Carbidopa—Constipation—Epirubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Carbidopa—Urticaria—Methotrexate—bone cancer	0.00129	0.0013	CcSEcCtD
Carbidopa—Abdominal pain—Methotrexate—bone cancer	0.00129	0.00129	CcSEcCtD
Carbidopa—Body temperature increased—Methotrexate—bone cancer	0.00129	0.00129	CcSEcCtD
Carbidopa—Insomnia—Doxorubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Carbidopa—Paraesthesia—Doxorubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Carbidopa—Dyspnoea—Doxorubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Carbidopa—Feeling abnormal—Epirubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Carbidopa—Somnolence—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Carbidopa—Gastrointestinal pain—Epirubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Carbidopa—Dyspepsia—Doxorubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Carbidopa—Decreased appetite—Doxorubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Carbidopa—Fatigue—Doxorubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Carbidopa—Urticaria—Epirubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Carbidopa—Constipation—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Carbidopa—Pain—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Carbidopa—Abdominal pain—Epirubicin—bone cancer	0.0012	0.00121	CcSEcCtD
Carbidopa—Body temperature increased—Epirubicin—bone cancer	0.0012	0.00121	CcSEcCtD
Carbidopa—Hypersensitivity—Methotrexate—bone cancer	0.0012	0.0012	CcSEcCtD
Carbidopa—Asthenia—Methotrexate—bone cancer	0.00117	0.00117	CcSEcCtD
Carbidopa—Feeling abnormal—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Carbidopa—Gastrointestinal pain—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Carbidopa—Pruritus—Methotrexate—bone cancer	0.00115	0.00115	CcSEcCtD
Carbidopa—Hypersensitivity—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Carbidopa—Urticaria—Doxorubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Carbidopa—Abdominal pain—Doxorubicin—bone cancer	0.00111	0.00112	CcSEcCtD
Carbidopa—Body temperature increased—Doxorubicin—bone cancer	0.00111	0.00112	CcSEcCtD
Carbidopa—Diarrhoea—Methotrexate—bone cancer	0.00111	0.00112	CcSEcCtD
Carbidopa—Asthenia—Epirubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Carbidopa—Pruritus—Epirubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Carbidopa—Dizziness—Methotrexate—bone cancer	0.00108	0.00108	CcSEcCtD
Carbidopa—Diarrhoea—Epirubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Carbidopa—Hypersensitivity—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Carbidopa—Vomiting—Methotrexate—bone cancer	0.00104	0.00104	CcSEcCtD
Carbidopa—Rash—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Carbidopa—Dermatitis—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Carbidopa—Headache—Methotrexate—bone cancer	0.00102	0.00102	CcSEcCtD
Carbidopa—Asthenia—Doxorubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Carbidopa—Dizziness—Epirubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Carbidopa—Pruritus—Doxorubicin—bone cancer	0.000998	0.000999	CcSEcCtD
Carbidopa—Vomiting—Epirubicin—bone cancer	0.000969	0.00097	CcSEcCtD
Carbidopa—Nausea—Methotrexate—bone cancer	0.000967	0.000968	CcSEcCtD
Carbidopa—Diarrhoea—Doxorubicin—bone cancer	0.000965	0.000966	CcSEcCtD
Carbidopa—Rash—Epirubicin—bone cancer	0.000961	0.000962	CcSEcCtD
Carbidopa—Dermatitis—Epirubicin—bone cancer	0.00096	0.000961	CcSEcCtD
Carbidopa—Headache—Epirubicin—bone cancer	0.000955	0.000956	CcSEcCtD
Carbidopa—Dizziness—Doxorubicin—bone cancer	0.000932	0.000933	CcSEcCtD
Carbidopa—Nausea—Epirubicin—bone cancer	0.000905	0.000906	CcSEcCtD
Carbidopa—Vomiting—Doxorubicin—bone cancer	0.000896	0.000898	CcSEcCtD
Carbidopa—Rash—Doxorubicin—bone cancer	0.000889	0.00089	CcSEcCtD
Carbidopa—Dermatitis—Doxorubicin—bone cancer	0.000888	0.000889	CcSEcCtD
Carbidopa—Headache—Doxorubicin—bone cancer	0.000883	0.000884	CcSEcCtD
Carbidopa—Nausea—Doxorubicin—bone cancer	0.000837	0.000838	CcSEcCtD
Carbidopa—Mesalazine—PTGS2—bone cancer	0.000734	0.63	CrCbGaD
Carbidopa—Epinephrine—CYP3A4—bone cancer	0.000432	0.37	CrCbGaD
